A real-world phase IV study to determine safety of the DTaP-IPV//Hib vaccine when administered in infants at 2, 4, and 6 months of age in South Korea
Latest Information Update: 20 Dec 2022
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary)
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions
Most Recent Events
- 20 Dec 2022 New trial record
- 15 Dec 2022 Results published in the Infectious Diseases and Therapy